media - ASD Healthcare

More documents

Recommendations

Info

Fluzone High-Dose vaccine—Because her immune systemisn’t 30 anymore.As patients reach 65 years of age and older, their immuneresponse to standard-dose influenza vaccines weakens, whichmay leave them at increased risk for infection. 1,2 In addition, 90%of influenza-related deaths occur in this age group. 3Only Fluzone High-Dose vaccine is specifically designed togive her a more robust immune response for this time in her life. 3,4SANOFI PASTEUR. Discovery Drive. Swiftwater, Pennsylvania 18370. www.sanofipasteur.usMKT25743 © 2012 Sanofi Pasteur Inc. 10/12 Printed in USA14 InsideOut
Covered underMedicarePart BIMPORTANT SAFETY INFORMATIONINDICATIONFluzone High-Dose vaccine is an inactivated infl uenza virus vaccine indicated for activeimmunization of persons 65 years of age and older against infl uenza disease caused byinfl uenza virus subtypes A and type B contained in the vaccine. Approval of Fluzone High-Dosevaccine is based on superior immune response relative to Fluzone vaccine. Data demonstratinga decrease in infl uenza disease after vaccination with Fluzone High-Dose vaccine relative toFluzone vaccine are not available.SAFETY INFORMATIONThe most common local and systemic adverse reactions to Fluzone High-Dose vaccine includepain, erythema, and swelling at the vaccination site; fever, headache, malaise, and myalgia. Otheradverse reactions may occur. Fluzone High-Dose vaccine should not be administered to anyonewith a severe allergic reaction (eg, anaphylaxis) to any vaccine component, including egg protein,or to a previous dose of any infl uenza vaccine.The decision to give Fluzone High-Dose vaccine should be based on the potential benefi tsand risks, especially if Guillain-Barré syndrome has occurred within 6 weeks of receipt of a priorinfl uenza vaccine. Vaccination with Fluzone High-Dose vaccine may not protect all individuals.Before administering Fluzone High-Dose vaccine, please see brief summary of full PrescribingInformation on next page.CPT ®a Code: 90662aCPT = Current Procedural Terminology is a registered trademark of the American Medical Association.Fluzone High-Dose vaccine is manufactured and distributed by Sanofi Pasteur Inc.To order Fluzone High-Dose vaccine or learn more about the Fluzone Partners Program,please visit VaccineShoppe.com ® or call 1-800-VACCINE (1-800-822-2463).References: 1. Monto AS, Ansaldi F, Aspinall R, et al. Infl uenza control in the 21st century: optimizing protection of older adults. Vaccine. 2009;27:5043-5053. 2. Goodwin K, Viboud C,Simonsen L. Antibody response to infl uenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24:1159-1169. 3. Centers for Disease Control and Prevention. Prevention and controlof infl uenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59(RR-8):1-61. 4. Fluzone High-Dose vaccine [PrescribingInformation]. Swiftwater, PA: Sanofi Pasteur Inc.; 2012.Senior Strength<strong>ASD</strong> <strong>Healthcare</strong> 15
Page 1 and 2: an ASD Healthcare publication Volum
Page 3 and 4: If you thInk they deliver the same
Page 5 and 6: Insideinform+connect+improveOutin t
Page 7 and 8: The ACA countdown has begun. On Jan
Page 10 and 11: KOGENATE FS [Antihemophilic Factor
Page 12 and 13: ★ ★ ★★ ★ ★★ ★ ★in
Page 14 and 15: ★ ★ ★★ ★ ★★ ★ ★WA
Page 18 and 19: 16 InsideOut
Page 20 and 21: in the newsThe MedicalMinuteStay in
Page 22 and 23: in the newsBottle Safest Betfor Som
Page 24 and 25: AFLURIA ® (Influenza Virus Vaccine
Page 26 and 27: in the spotlightOn January 1, 2014,
Page 28 and 29: 85%With the ACA, 85 percent of each
Page 30 and 31: in the spotlightMaking History Toge
Page 32 and 33: 30 InsideOut
Page 34 and 35: in the spotlightAdvocacyConnectionT
Page 36 and 37: Privigen ®Immune Globulin Intraven
Page 38 and 39: CommunityBenefitsPreserving Access
Page 40 and 41: 21% numberincreasein theof physicia
Page 43 and 44: Be creative.“We develop some pret
Page 45 and 46: FREE TRIAL Help your eligible patie
Page 47 and 48: in our catalogASD Healthcare Produc
Page 49 and 50: Go to www.asdhealthcare.com for pri
Page 67 and 68:
Go to www.asdhealthcare.com for pri
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
in the worksClinicalTrialsPatients
Page 79 and 80:
HyperRHO® S/DFull DoseRho(D) Immun
show all

media - ASD Healthcare

Create successful ePaper yourself

Delete template?

Save as template?